Medroxyprogesterone acetate supplementation diminishes the hypoestrogenic side effects of gonadotropin-releasing hormone agonist without changing its efficacy in endometriosis

Leo Mäkäräinen, L Mäkäräinen, Lars Rönnberg, L Rönnberg, A Kauppila, Antti Kauppila
Fertility and Sterility · 1996 · vol. 65(1) , pp. 29–34 · doi:10.1016/s0015-0282(16)58023-6 · PMID:8557151 · W35401484
article OA: closed CC0 ⤵ 35 in-corpus citations
Limited metadata. Only one source feed has indexed this record so far — no abstract, full text, or open-access copy is available through Endo Lab. The publisher's page (linked below) is the canonical location for the actual content. If you have institutional access, use "Find at my library".
View at publisher → View on OpenAlex View on PubMed

My notes (saved in your browser only)

Condition tags

mesh:D004715endometriosis

MeSH descriptors

Endometriosis Estrogen Antagonists Goserelin Medroxyprogesterone Acetate Adult Double-Blind Method Drug Therapy, Combination Endometriosis Estrogen Antagonists Female Goserelin Goserelin Humans Medroxyprogesterone Acetate Sex Hormone-Binding Globulin Sex Hormone-Binding Globulin

Citation neighborhood

Papers in the corpus that this work cites (lower rings, blue) and that cite this one (upper rings, green). Dot size scales with the paper's in-corpus citation count — bigger dot = more influential within the endo/adeno field. Click a dot to open that paper. [ expand to 2 hops ] — adds papers reached through this work's immediate citers/citees. Heavier; up to 60 extra dots.

References (31)

Cited by (35)

Source provenance

europepmc
last seen: 2026-06-04T01:30:01.192114+00:00
openalex
last seen: 2026-06-10T17:14:06.276822+00:00
pubmed
last seen: 2026-05-13T22:11:08.331550+00:00
License: CC0 · commercial use OK